All

Greetings from those of us at the Midwest Lipid Association (MWLA). We all trust that you had an excellent summer as we head into cooler weather and color changes up here in the Midwest and Canada. For those of you who do not know, our Canadian partners who are National Lipid Association (NLA)... more

0
No votes yet

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more

Section:

0
No votes yet

When the task of writing the quarterly Lipid Spin was announced at our Board meeting, the vast geographical 11 state volunteers immediately responded. The knowledge, talent, skills and passion expressed show the commitment and specialized expertise of the membership. Their enthusiasm for... more

0
No votes yet

I hope everyone had a wonderful Holiday Season and a Happy New Year! To kick off the New Year, the Foundation of the National Lipid Association (FNLA) is hard at work with new projects and partnerships. Most recently, the FNLA collaborated with Sanofi US and Regeneron Pharmaceuticals Inc. in... more

0
No votes yet

0
No votes yet

It is my privilege to serve as President of the NLA during this coming year. As is always the case, this is both an exciting but also a very challenging time. I would like to tell you about some of the programs and initiatives we are rolling out this year. In September, we are convening a panel of... more

0
No votes yet

Join us for our virtual business meeting! On behalf of the National Lipid Association, the 2020 Annual Business Meeting will be held electronically Monday, June 8, 2020 from 6:00-6:30 PM ET. Agenda: President’s Introduction Secretary / Treasurer’s Report Nominating... more

Section:

0
No votes yet

Please review, rate and comment photos frpm the NLA Spring Clinical Lipid Update.

The National Lipid Association has featured highlights from selected presentations at the 2016 Scientific Sessions in New Orleans. Read our meeting coverage here. more

Evaluation of a patient’s risk for cardiovascular disease (CVD) is the basis of deciding whether to institute statin therapy. The 2013 ACC/AHA Guidelines on the Assessment of Cardiovascular Risk recommend using the Pooled Cohort Equation to predict the 10-year risk of having an atherosclerotic... more

0
No votes yet